chrX-3010142-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001011719.2(ARSH):āc.205A>Gā(p.Ile69Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,209,234 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001011719.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSH | NM_001011719.2 | c.205A>G | p.Ile69Val | missense_variant | 2/9 | ENST00000381130.3 | NP_001011719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSH | ENST00000381130.3 | c.205A>G | p.Ile69Val | missense_variant | 2/9 | 1 | NM_001011719.2 | ENSP00000370522.3 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 17AN: 111979Hom.: 0 Cov.: 23 AF XY: 0.000205 AC XY: 7AN XY: 34129
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 181718Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66278
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1097202Hom.: 0 Cov.: 30 AF XY: 0.00000827 AC XY: 3AN XY: 362580
GnomAD4 genome AF: 0.000152 AC: 17AN: 112032Hom.: 0 Cov.: 23 AF XY: 0.000205 AC XY: 7AN XY: 34192
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.205A>G (p.I69V) alteration is located in exon 2 (coding exon 2) of the ARSH gene. This alteration results from a A to G substitution at nucleotide position 205, causing the isoleucine (I) at amino acid position 69 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at